IXCINVEX THERAPEUTICS LTD
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 24 July 2026, 04:14 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 24 Apr 2026, 22:13 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 24 Apr 2026, 18:11 | Invex to Expand Preclinical Research Program | Company Update | — | 11001 | |
| 23 Mar 2026, 23:27 | Resignation of Joint Company Secretary | Company Administration | — | 12007 | |
| 18 Feb 2026, 05:40 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 13 Feb 2026, 00:34 | Appendix 4D and Half Year Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 23 Jan 2026, 03:16 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 | |
| 16 Jan 2026, 23:38 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 21 Nov 2025, 07:23 | Deferral of Annual General Meeting | Meetings & Governance | — | 08005 | |
| 11 Nov 2025, 00:02 | Initial Director's Interest Notice x 2 | Director Interests | — | 02008 | |
| 10 Nov 2025, 20:38 | Reinstatement to Quotation | Reinstatement | MS | 09002 | |
| 10 Nov 2025, 20:37 | Board and Officer Appointments and Company Address Change | Company Administration | MS | 12001, 12003, 12007 | |
| 8 Nov 2025, 02:44 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 8 Nov 2025, 02:22 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 8 Nov 2025, 02:22 | Resignation of Directors, Co Sec and Cancellation of Meeting | Meetings & Governance | — | 08006, 12001, 12007, 12008 | |
| 8 Nov 2025, 01:41 | Suspension from Official Quotation | Trading Halt / Suspension | MS | 09001 | |
| 8 Nov 2025, 01:20 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 4 Nov 2025, 01:11 | Exenatide shows additional positive benefits in brain model | Company Update | — | 08006, 11001 | |
| 25 Oct 2025, 02:07 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004, 16002 | |
| 18 Oct 2025, 03:02 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 9 Oct 2025, 02:34 | Notice of General Meeting/Proxy Form | Meetings & Governance | — | 08004, 08007, 16002 | |
| 3 Oct 2025, 19:16 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 30 Sept 2025, 19:55 | Reinstatement to Quotation | Reinstatement | MS | 09002 | |
| 30 Sept 2025, 19:55 | Response to ASX Price and Volume Query | ASX Query | MS | 17003 | |
| 30 Sept 2025, 19:55 | Corporate Update | Company Update | MS | 11001 | |
| 29 Sept 2025, 22:09 | Director Nominations AGM | Meetings & Governance | — | 08006, 12008 | |
| 29 Sept 2025, 19:27 | Request for extension to voluntary suspension | Other | — | 11003 | |
| 25 Sept 2025, 19:40 | Suspension from Quotation | Trading Halt / Suspension | MS | 09001 | |
| 23 Sept 2025, 21:35 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 23 Sept 2025, 20:38 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 18 Sept 2025, 20:42 | Notices received under sections 203D(2) and 249D of Corp Act | Company Administration | — | 12008 | |
| 11 Aug 2025, 19:39 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 11 Aug 2025, 18:22 | Appendix 4E and Annual Report to shareholders | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 |
1–33 of 33
1 / 1